Multiple Polymorphisms Affect Expression and Function of the Neuropeptide S Receptor (NPSR1).

Multiple Polymorphisms Affect Expression and Function of the Neuropeptide S Receptor (NPSR1).

PLoS One. 2011;6(12):e29523

Authors: Anedda F, Zucchelli M, Schepis D, Hellquist A, Corrado L, D’Alfonso S, Achour A, McInerney G, Bertorello A, Lördal M, Befrits R, Björk J, Bresso F, Törkvist L, Halfvarson J, Kere J, D’Amato M

Abstract
BACKGROUND: neuropeptide S (NPS) and its receptor NPSR1 act along the hypothalamic-pituitary-adrenal axis to modulate anxiety, fear responses, nociception and inflammation. The importance of the NPS-NPSR1 signaling pathway is highlighted by the observation that, in humans, NPSR1 polymorphism associates with asthma, inflammatory bowel disease, rheumatoid arthritis, panic disorders, and intermediate phenotypes of functional gastrointestinal disorders. Because of the genetic complexity at the NPSR1 locus, however, true causative variations remain to be identified, together with their specific effects on receptor expression or function. To gain insight into the mechanisms leading to NPSR1 disease-predisposing effects, we performed a thorough functional characterization of all NPSR1 promoter and coding SNPs commonly occurring in Caucasians (minor allele frequency >0.02).
PRINCIPAL FINDINGS: we identified one promoter SNP (rs2530547 [-103]) that significantly affects luciferase expression in gene reporter assays and NPSR1 mRNA levels in human leukocytes. We also detected quantitative differences in NPS-induced genome-wide transcriptional profiles and CRE-dependent luciferase activities associated with three NPSR1 non-synonymous SNPs (rs324981 [Ile107Asn], rs34705969 [Cys197Phe], rs727162 [Arg241Ser]), with a coding variant exhibiting a loss-of-function phenotype (197Phe). Potential mechanistic explanations were sought with molecular modelling and bioinformatics, and a pilot study of 2230 IBD cases and controls provided initial support to the hypothesis that different cis-combinations of these functional SNPs variably affect disease risk.
SIGNIFICANCE: these findings represent a first step to decipher NPSR1 locus complexity and its impact on several human conditions NPS antagonists have been recently described, and our results are of potential pharmacogenetic relevance.

PMID: 22216302 [PubMed – in process]

View full post on pubmed: asthma

Asthma drug helps with Multiple sclerosis treatment – Health Jackal


MedIndia

Asthma drug helps with Multiple sclerosis treatment
Health Jackal
The results of a new study show that by adding albuterol, a drug normally used to treat asthma and other respiratory diseases, to an existing treatment for
Health Minute: Asthma medication helpful for MS patientsExaminer.com
Asthma drug can help treat MSPress TV
Asthma Drug Can Prove Effective for MS PatientsTopNews United Kingdom (blog)
Stuff.co.nz –Oneindia –The Pharma Letter (subscription)
all 75 news articles »

View full post on asthma – Google News

Asthma Medication May Help Patients With Multiple Sclerosis – Ivanhoe


Health Jackal

Asthma Medication May Help Patients With Multiple Sclerosis
Ivanhoe
(Ivanhoe Newswire) – Albuterol Sulfate, a compound commonly used to treat asthma and other respiratory diseases, may decrease levels of a biological
Asthma Drug Albuterol May Help Treat MSWebMD
Asthma drug may help MS patientsTehran Times
Common Asthma Drug Could Speed MS TreatmentBusinessWeek
Reuters –Los Angeles Times –The Money Times
all 67 news articles »

View full post on asthma – Google News

Asthma drug may help multiple sclerosis patients–study – The Money Times


Health Jackal

Asthma drug may help multiple sclerosis patients–study
The Money Times
Buterol, a compound commonly used to treat asthma and other respiratory diseases, can help treat multiple sclerosis, a new study has found.
Asthma Drug Albuterol May Help Treat MSWebMD
Common Asthma Drug Could Speed MS TreatmentBusinessWeek
Asthma drug albuterol improves multiple sclerosis when added to conventional Los Angeles Times
Reuters –Medical News Today –MedPage Today
all 55 news articles »

View full post on asthma – Google News

Asthma Drug Albuterol May Benefit Multiple Sclerosis Patients – Medical News Today


Health Jackal

Asthma Drug Albuterol May Benefit Multiple Sclerosis Patients
Medical News Today
Multiple sclerosis patients who have albuterol, a medication used to treat asthma and some respiratory diseases, added to their treatment appear to benefit
Asthma Drug Albuterol May Help Treat MSWebMD
Common Asthma Drug Could Speed MS TreatmentBusinessWeek
Asthma drug albuterol improves multiple sclerosis when added to conventional Los Angeles Times
Reuters –MedPage Today –eMaxHealth
all 54 news articles »

View full post on asthma – Google News

Asthma Drug Improves Multiple Sclerosis Outcomes – eMaxHealth


Health Jackal

Asthma Drug Improves Multiple Sclerosis Outcomes
eMaxHealth
A medication used to treat asthma and COPD has been found to improve clinical outcomes for patients with multiple sclerosis, especially during the first
Common Asthma Drug Could Speed MS TreatmentBusinessWeek
Asthma drug albuterol improves multiple sclerosis when added to conventional Los Angeles Times
Asthma drug may help multiple sclerosis: studyReuters
MedPage Today –Xinhua –Health Jackal
all 30 news articles »

View full post on asthma – Google News